Streetbeat News

Earnings

NATL

NCR Atleos has released its Q3 financial guidance, projecting adjusted EPS between $0.71 and $0.81, which is above the estimated $0.69. However, the company expects revenue to be between $1.045 billion and $1.075 billion, slightly below the estimated $1.081 billion.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:33 pm

USPH

U.S. Physical Therapy has revised its guidance for adjusted EBITDA for 2024 back to its original range of $80 million to $85 million.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:33 pm

SND

Smart Sand (NASDAQ:SND) reported Q2 2024 GAAP EPS of $(0.01), meeting analyst expectations. The company achieved sales of $73.8 million, surpassing the $68.15 million estimate by 8.29%, despite a 1.31% year-over-year decline.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:33 pm

USPH

US Physical Therapy (NYSE:USPH) reported Q2 earnings of $0.73 per share, missing the analyst estimate of $0.82. However, sales were $167.19 million, beating the estimate of $162.35 million. Earnings decreased by 3.95% year-over-year, while sales increased by 10.37%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:33 pm

LULU

Whales have shown a bullish stance on Lululemon Athletica (NASDAQ:LULU) with 56% of options trades being bullish. The stock is currently trading at $241.95, up by 0.94%. Analysts have mixed ratings with price targets ranging from $286 to $470.

Portfolio Pulse from Benzinga Insights

August 13, 2024 | 8:31 pm

RDZN

Roadzen (NASDAQ:RDZN) reported a significant improvement in its Q1 financial results. The company posted a loss of $(0.71) per share, an 89.45% improvement from the $(6.73) loss per share in the same period last year. Sales increased by 59.18% to $8.93 million from $5.61 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:31 pm

BTBD

BT Brands (NASDAQ:BTBD) reported a Q2 EPS of $(0.01), an improvement from $(0.04) YoY, and sales of $4.11M, up from $4.00M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:30 pm

GRTS

Gritstone Bio (NASDAQ:GRTS) reported Q2 earnings per share (EPS) of $(0.16), beating the analyst estimate of $(0.29) by 44.83%. However, the company missed sales estimates, reporting $921K against the expected $1.44M, a 35.82% shortfall. Compared to the same period last year, EPS improved by 48.39%, but sales decreased by 52.89%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:29 pm

DYAI

Dyadic International (NASDAQ:DYAI) reported Q2 2024 GAAP EPS of $(0.07), meeting analyst estimates, but missed sales expectations with $385.896K, a 53.90% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:29 pm

NU

Nu Holdings shares are trading higher after the company reported Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:27 pm